CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 6462005278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-09-16 | SCHWARTZ MARK W. President & CEO | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2014-07-28 | Kivinski Margaret VP and General Counsel | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2014-06-30 | Ahn Mark J President & CEO | Grant or award | +2,461 | $2.60 | $6K | 116,225 |
| 2014-06-30 | SCHWARTZ MARK W. EVP, Chief Operating Officer | Other acquisition | +2,461 | $2.60 | $6K | 412,126 |
| 2014-06-30 | HAMILTON BRIAN L EVP, Chief Medical Officer | Other acquisition | +2,461 | $2.60 | $6K | 2,461 |
| 2014-06-30 | Dunlap Ryan VP, Chief Financial Officer | Other acquisition | +2,461 | $2.60 | $6K | 7,804 |
| 2014-06-30 | Ahn Mark J President & CEO | Other acquisition | +2,461 | $2.60 | $6K | 116,225 |
| 2014-04-18 | Einhorn Irving M. Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2014-02-12 | Chin Richard Director | Option exercise | +50,000 | $2.31 | $116K | 50,000 |
| 2014-02-12 | Chin Richard Director | Option exercise | +100,000 | $1.18 | $118K | 150,000 |
| 2014-02-12 | Chin Richard Director | Option exercise | +37,500 | $1.71 | $64K | 187,500 |
| 2014-02-12 | Chin Richard Director | Sale | −187,500 | $4.33 | $812K | 0 |
| 2014-02-12 | Chin Richard Director | Option exercise · Stock Option (right to buy) | −50,000 | 0 | ||
| 2014-02-12 | Chin Richard Director | Option exercise · Stock Option (right to buy) | −100,000 | 0 | ||
| 2014-02-12 | Chin Richard Director | Option exercise · Stock Option (right to buy) | −37,500 | 12,500 | ||
| 2014-02-07 | Nisi Rudolph Director | Purchase | +20,000 | $4.94 | $99K | 23,500 |
| 2014-02-03 | GALLIKER STEPHEN S Director | Option exercise | +50,000 | $2.31 | $116K | 60,000 |
| 2014-02-03 | GALLIKER STEPHEN S Director | Option exercise | +100,000 | $1.18 | $118K | 160,000 |
| 2014-02-03 | GALLIKER STEPHEN S Director | Option exercise | +50,000 | $0.85 | $43K | 210,000 |
| 2014-02-03 | GALLIKER STEPHEN S Director | Option exercise | +50,000 | $0.72 | $36K | 260,000 |
Page 13 of 17 · 324 trades